Fresenius | FRE - Capital Ordinário





Capital Ordinário Alterar Data
Akzo Nobel EUR 171.31M 200K 2026-03
Alcon AG USD 487.4M 0 2026-03
AstraZeneca USD 1.55B 73K 2026-03
BASF EUR 892.52M 249.48M 2025-09
Bayer EUR 982.42M 0 2025-12
Beiersdorf EUR 218.92M 1.29M 2025-12
DaVita Healthcare Partners USD 66.18M 2.36M 2026-03
Demant DKK 210.9M 5.18M 2025-12
E.ON EUR 2.61B 0 2026-03
Essilor EUR 463.05M 1.9M 2025-12
Fresenius EUR 563.24M 0 2025-12
Fresenius Medical Care EUR 270.09M 9.2M 2026-03
Getinge SEK 136M 0 2024-12
Givaudan CHF 9.23M 0 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
GN Store Nord DKK 145.61M 0 2026-03
GRIFOLS EUR 680.58M 0 2026-03
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2026-03
Novartis USD 1.91B 60K 2026-03
Philips EUR 952.02M 729K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
RWE EUR 713.56M 0 2026-03
Sanofi EUR 1.21B 8.25M 2026-03
Smith & Nephew USD 875.96M 1.61M 2025-12